E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease

Pudutha Madhavi, M Vanitha.

Abstract
Background: A significant public health concern, both preventable and treatable, is chronic pulmonary obstructive disorders (Chronic obstructive pulmonary disease [COPD]). It is one of the primary causes of chronic illness and mortality worldwide. The prominent safety concerns in the use of theophylline need to be addressed.

Aim and Objective: In Grade 12 COPD patients, the efficacy and effectiveness of oral doxofylline should be contrasted with theophylline.

Materials and Methods: Two groups of 25 patients, with one group getting theophylline and the other doxofylline, were randomized to a total of 50 patients in addition to the normal treatment for 12 weeks. Each patient was accompanied by a pulmonary function test (PFT), a COPD assessment test (CAT) evaluation questionnaire, and a drug-related safety review at 6 weeks and 12 weeks for the assessment of efficacy parameters.

Results: At 6 weeks and 12 weeks within their respective classes, theophylline and doxofylline showed substantial increases in PFT and CAT performance. However, there was no noticeable change relative to the two classes. In theophylline group, the amount of adverse drug reactions is larger relative to patients in the doxofylline community. Dyspnea was the most severe harmful effect of all categories.

Conclusion: Doxofylline is also useful in treating Grade 12 COPD (global obstructive lung disease criteria), which has a greater safety profile relative to theophylline.

Key words: Doxofylline; Chronic Pulmonary Obstructive Disease; Chronic Obstructive Pulmonary Disease; Theophylline


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pudutha Madhavi
Articles by M Vanitha
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Madhavi P, Vanitha M. Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease. Natl J Physiol Pharm Pharmacol. 2021; 11(4): 397-400. doi:10.5455/njppp.2021.11.09243202014122020


Web Style

Madhavi P, Vanitha M. Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease. http://www.njppp.com/?mno=134961 [Access: April 01, 2021]. doi:10.5455/njppp.2021.11.09243202014122020


AMA (American Medical Association) Style

Madhavi P, Vanitha M. Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease. Natl J Physiol Pharm Pharmacol. 2021; 11(4): 397-400. doi:10.5455/njppp.2021.11.09243202014122020



Vancouver/ICMJE Style

Madhavi P, Vanitha M. Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease. Natl J Physiol Pharm Pharmacol. (2021), [cited April 01, 2021]; 11(4): 397-400. doi:10.5455/njppp.2021.11.09243202014122020



Harvard Style

Madhavi, P. & Vanitha, . M. (2021) Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease. Natl J Physiol Pharm Pharmacol, 11 (4), 397-400. doi:10.5455/njppp.2021.11.09243202014122020



Turabian Style

Madhavi, Pudutha, and M Vanitha. 2021. Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease. National Journal of Physiology, Pharmacy and Pharmacology, 11 (4), 397-400. doi:10.5455/njppp.2021.11.09243202014122020



Chicago Style

Madhavi, Pudutha, and M Vanitha. "Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 397-400. doi:10.5455/njppp.2021.11.09243202014122020



MLA (The Modern Language Association) Style

Madhavi, Pudutha, and M Vanitha. "Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease." National Journal of Physiology, Pharmacy and Pharmacology 11.4 (2021), 397-400. Print. doi:10.5455/njppp.2021.11.09243202014122020



APA (American Psychological Association) Style

Madhavi, P. & Vanitha, . M. (2021) Comparing the efficacy and safety of theophylline with doxofylline in patients with chronic obstructive pulmonary disease. National Journal of Physiology, Pharmacy and Pharmacology, 11 (4), 397-400. doi:10.5455/njppp.2021.11.09243202014122020